Hall MC - Search Results

1

Recent advances in the treatment of bladder cancer.

Gwynn ES, Clark PE, Hall MC. Gwynn ES, et al. Among authors: hall mc. Expert Rev Anticancer Ther. 2005 Dec;5(6):1023-30. doi: 10.1586/14737140.5.6.1023. Expert Rev Anticancer Ther. 2005. PMID: 16336093 Review.

2

Bladder cancer.

Borden LS Jr, Clark PE, Hall MC. Borden LS Jr, et al. Among authors: hall mc. Curr Opin Oncol. 2003 May;15(3):227-33. doi: 10.1097/00001622-200305000-00009. Curr Opin Oncol. 2003. PMID: 12778017 Review.

3

Bladder cancer.

Borden LS Jr, Clark PE, Hall MC. Borden LS Jr, et al. Among authors: hall mc. Curr Opin Oncol. 2004 May;16(3):257-62. doi: 10.1097/00001622-200405000-00012. Curr Opin Oncol. 2004. PMID: 15069323 Review.

4

Bladder cancer.

Borden LS Jr, Clark PE, Hall MC. Borden LS Jr, et al. Among authors: hall mc. Curr Opin Oncol. 2005 May;17(3):275-80. doi: 10.1097/01.cco.0000156985.47984.9e. Curr Opin Oncol. 2005. PMID: 15818174 Review.

5

Contemporary management of the urethra in patients after radical cystectomy for bladder cancer.

Clark PE, Hall MC. Clark PE, et al. Among authors: hall mc. Urol Clin North Am. 2005 May;32(2):199-206. doi: 10.1016/j.ucl.2005.01.004. Urol Clin North Am. 2005. PMID: 15862617 Review.

6

Does a delay in initiating definitive therapy affect biochemical recurrence rates in men with clinically localized prostate cancer?

Phillips JJ, Hall MC, Lee WR, Clark PE. Phillips JJ, et al. Among authors: hall mc. Urol Oncol. 2007 May-Jun;25(3):196-200. doi: 10.1016/j.urolonc.2006.06.004. Urol Oncol. 2007. PMID: 17483015

7

Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma.

Clark PE, Hall MC, Miller A, Ridenhour KP, Stindt D, Lovato JF, Patton SE, Brinkley W, Das S, Torti FM. Clark PE, et al. Among authors: hall mc. Urology. 2004 Jun;63(6):1061-5. doi: 10.1016/j.urology.2004.01.035. Urology. 2004. PMID: 15183950 Clinical Trial.

8

Utility of frozen section analysis of resection margins during partial nephrectomy.

Kubinski DJ, Clark PE, Assimos DG, Hall MC. Kubinski DJ, et al. Among authors: hall mc. Urology. 2004 Jul;64(1):31-4. doi: 10.1016/j.urology.2004.03.011. Urology. 2004. PMID: 15245928 Review.

9

Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.

Clark PE, Veys JA, Eskridge MR, Woodruff RD, Hall MC. Clark PE, et al. Among authors: hall mc. Urol Oncol. 2005 Sep-Oct;23(5):328-32. doi: 10.1016/j.urolonc.2005.01.017. Urol Oncol. 2005. PMID: 16144666

10

DNA damage levels in prostate cancer cases and controls.

Lockett KL, Hall MC, Clark PE, Chuang SC, Robinson B, Lin HY, Su LJ, Hu JJ. Lockett KL, et al. Among authors: hall mc. Carcinogenesis. 2006 Jun;27(6):1187-93. doi: 10.1093/carcin/bgi288. Epub 2005 Dec 19. Carcinogenesis. 2006. PMID: 16364923

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

247 results

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

247 results